Anebulo Pharmaceuticals, Inc. (ANEB)
Company Info
| ISIN | US0345691036 |
|---|---|
| CUSIP | 034569103 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $55.11M |
|---|---|
| EPS | -$0.46 |
| Year Range | $1.62 - $4.05 |
| Target Price | $6.50 |
| Short % | 0.15% |
| Short Ratio | 0.22 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Anebulo Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Anebulo Pharmaceuticals, Inc. had a return of -11.29% year-to-date (YTD) and -18.56% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -11.29% | 18.20% |
| 1 month | -19.78% | 7.43% |
| 6 months | -11.52% | 9.47% |
| 1 year | -18.56% | 14.89% |
| 5 years (annualized) | N/A | 11.39% |
| 10 years (annualized) | N/A | 9.68% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 0.69% | -22.60% | 3.98% | -8.09% | 29.17% | 9.50% | -27.99% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Anebulo Pharmaceuticals, Inc. (ANEB) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ANEB Anebulo Pharmaceuticals, Inc. | -0.17 | ||||
^GSPC S&P 500 | 1.01 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Anebulo Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Anebulo Pharmaceuticals, Inc. was 80.89%, occurring on Oct 16, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -80.89% | May 24, 2021 | 550 | Oct 16, 2023 | — | — | — |
| -1.41% | May 10, 2021 | 7 | May 18, 2021 | 1 | May 19, 2021 | 8 |
Volatility Chart
The current Anebulo Pharmaceuticals, Inc. volatility is 20.80%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.